What is the recommended acute and preventive management of migraine in pediatric patients?

Paediatric Migraine Management

For acute treatment in children and adolescents, use ibuprofen as first-line therapy; in adolescents, consider adding sumatriptan nasal spray or other triptans if ibuprofen fails, and for preventive therapy, engage in shared decision-making with families about the limited evidence for medications over placebo, with topiramate and propranolol showing the most promise, while amitriptyline combined with cognitive behavioral therapy demonstrates the strongest evidence for prevention. 1

Acute Management

First-Line Treatment

• Ibuprofen is the primary acute treatment for all pediatric patients 1
• Treat early in the attack—waiting reduces efficacy 1
• Dose appropriately for age and weight 2

Second-Line Options for Adolescents

When ibuprofen alone is insufficient, consider:

• Sumatriptan nasal spray (most evidence-based triptan for pediatrics) 1, 3
• Zolmitriptan nasal spray 1
• Rizatriptan ODT 1
• Almotriptan oral 1
• Sumatriptan/naproxen combination oral 1

Triptan Strategy

• If one triptan fails, try another or combine with an NSAID 1
• For rapidly spiking pain: use non-oral formulations (nasal sprays) 1
• For prominent nausea/vomiting: use non-oral triptans or add antiemetics 1

Emergency Department Setting

When presenting to ED with acute migraine:

• Metoclopramide is first-line 4
• Second-line options: occipital nerve blocks, intranasal lidocaine 4
• Never use opioids for migraine treatment—this is a critical pitfall that can lead to medication overuse and worsening headache patterns 4

Preventive Management

When to Consider Prevention

Initiate preventive therapy for:

• Frequent headaches (typically ≥4 per month)
• Disabling headaches affecting school/quality of life 1
• Medication overuse 1

Critical Counseling Point

Before starting any preventive medication, discuss with patients and families that placebo was as effective as active medication in many pediatric trials 1, 5. This shared decision-making is essential—many families may prefer non-pharmacologic approaches given this evidence.

Preventive Medication Options

Strongest Evidence:

• Amitriptyline combined with cognitive behavioral therapy (most robust evidence for efficacy) 1, 5
• Topiramate (probably effective, reduces headache frequency) 1, 5
• Propranolol (possibly effective for ≥50% reduction in frequency) 1, 5

Insufficient Evidence (no better than placebo in trials):

• Amitriptyline alone 1, 5
• Divalproex 1, 5
• OnabotulinumtoxinA 1, 5
• Nimodipine 1

Preventive Medication Caveats

• Topiramate and valproate are teratogenic—counsel adolescent females on effective contraception and folate supplementation 1
• Titrate dose gradually to maximize benefit while minimizing side effects 2
• Trial for minimum 6-8 weeks before judging efficacy 2
• Use prospective headache diaries to monitor response 2

Non-Pharmacologic Management (Essential for All Patients)

Lifestyle Modifications

• Regular sleep schedule 1, 2
• Regular meal times 1, 2
• Consistent exercise routine 1, 2
• Moderate caffeine intake 1
• Identify and avoid individual triggers 1, 2

Behavioral Interventions

• Cognitive behavioral therapy (particularly effective when combined with amitriptyline) 1, 5
• Biofeedback 2
• Relaxation techniques 2

Critical Pitfall: Medication Overuse

• Counsel on avoiding acute medication overuse (typically >2-3 days per week) 1
• This can transform episodic migraine into chronic daily headache
• Address early if suspected

Comorbidity Management

Assess and treat comorbid conditions that influence headache persistence:

• Anxiety and depression 5
• Sleep disorders 5
• Other pain conditions 5

Algorithmic Approach

1. Confirm diagnosis using ICHD-3 criteria 1
2. Assess disability using PedMIDAS scale 3
3. Educate on lifestyle factors and triggers for all patients 1
4. Provide acute treatment: ibuprofen first-line; add triptans (nasal formulations) for adolescents if needed 1
5. Consider prevention if ≥4 headaches/month or significant disability 1
6. Shared decision-making discussion about limited medication evidence vs. placebo 1, 5
7. If choosing medication: topiramate, propranolol, or amitriptyline + CBT (strongest options) 1, 5
8. Monitor with headache diary for 6-8 weeks minimum 2
9. Reassess and adjust based on response and tolerability